Medical and Pharmaceutical Johnson & Johnson may bankrupt a subsidiary to pay USD$6.9B talcum cancer settlements J&J plans to place a subsidiary into bankruptcy if at least 75 per cent of the talc claimants vote for its settlement proposal Joseph MortonAugust 28, 2024